Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Molecular Templates	AC Immune	Verastem	XBiotech	Avadel Pharmaceuticals
Symbol	NASDAQ:MTEM	NASDAQ:ACIU	NASDAQ:VSTM	NASDAQ:XBIT	NASDAQ:AVDL
Price Information
Current Price	$8.81	$6.15	$2.85	$17.04	$8.17
52 Week Range	Buy	Buy	Buy	N/A	Buy
MarketRank™
Overall Score	2.0	1.3	1.1	1.0	1.5
Analysis Score	3.4	3.5	1.5	0.0	3.5
Community Score	2.6	2.4	2.6	3.1	2.4
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	3.3	0.0	0.8	0.0	0.8
Earnings & Valuation Score	0.6	0.6	0.6	1.9	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	N/A	Buy
Consensus Price Target	$14.50	$16.00	$3.00	N/A	$18.75
% Upside from Price Target	64.59% upside	160.16% upside	5.26% upside	N/A	129.50% upside
Trade Information
Market Cap	$494.14 million	$446.82 million	$489.25 million	$510.91 million	$477.66 million
Beta	2.08	0.82	0.72	1.5	1.55
Average Volume	443,700	749,984	2,736,875	96,216	440,739
Sales & Book Value
Annual Revenue	$22.27 million	$111.75 million	$17.46 million	N/A	$59.22 million
Price / Sales	22.19	4.00	28.02	N/A	8.07
Cashflow	N/A	$0.69 per share	N/A	N/A	N/A
Price / Cash	N/A	8.97	N/A	N/A	N/A
Book Value	$2.79 per share	$4.06 per share	$0.09 per share	$18.20 per share	($0.78) per share
Price / Book	3.16	1.51	31.67	N/A	-10.47
Profitability
Net Income	$-69,420,000.00	$45.74 million	$-149,210,000.00	$668.63 million	$-33,230,000.00
EPS	($1.26)	$0.60	($2.00)	N/A	($0.89)
Trailing P/E Ratio	N/A	N/A	N/A	1.18	40.85
Forward P/E Ratio	N/A	N/A	N/A	∞	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-428.65%	-392.56%	-590.19%	N/A	38.70%
Return on Equity (ROE)	-111.43%	-23.88%	-189.37%	-7.07%	-33.91%
Return on Assets (ROA)	-56.35%	-21.85%	-67.69%	-6.67%	-11.75%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.18%	N/A	0.45%	N/A	0.74%
Current Ratio	3.21%	18.10%	5.02%	18.28%	12.24%
Quick Ratio	3.21%	18.10%	4.80%	18.28%	12.24%
Ownership Information
Institutional Ownership Percentage	60.73%	27.68%	42.15%	14.79%	53.78%
Insider Ownership Percentage	38.20%	N/A	2.90%	30.98%	1.41%
Miscellaneous
Employees	228	125	48	91	32
Shares Outstanding	56.09 million	72.65 million	171.67 million	29.98 million	58.47 million
Next Earnings Date	5/10/2021 (Estimated)	8/4/2021 (Estimated)	N/A	5/10/2021 (Estimated)	5/10/2021 (Confirmed)
Optionable	Not Optionable	Not Optionable	Optionable	Optionable	Optionable

Source	Headline
	Zacks: Brokerages Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) Will Announce Earnings of -$0.32 Per Share americanbankingnews.com - May 5 at 5:18 PM
	Avadel Pharmaceuticals (AVDL) Set to Announce Quarterly Earnings on Monday americanbankingnews.com - May 3 at 9:30 AM
	Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2021 Financial Results on May 10th markets.businessinsider.com - April 29 at 10:31 AM
	Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2021 Financial Results on May 10th finance.yahoo.com - April 29 at 10:31 AM
	Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL) americanbankingnews.com - April 28 at 9:44 AM
	Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of "Buy" by Analysts americanbankingnews.com - April 24 at 4:54 AM
	Avadel's Formulated Sodium Oxybate Shows Improved Sleepiness, Sleep Quality In Narcolepsy Patients finance.yahoo.com - April 19 at 12:40 PM
	Avadel Presents New Data from its Pivotal REST-ON... benzinga.com - April 18 at 8:01 PM
	Brokerages Anticipate Avadel Pharmaceuticals plc (NASDAQ:AVDL) to Announce -$0.32 EPS americanbankingnews.com - April 18 at 4:44 PM
	Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium ... apnews.com - April 17 at 12:36 PM
	Head-To-Head Analysis: Avadel Pharmaceuticals (NASDAQ:AVDL) versus Xeris Pharmaceuticals (NASDAQ:XERS) americanbankingnews.com - April 15 at 6:54 AM
	Avadel to Present New Data from its Pivotal REST-ON Phase 3 Study of FT218 at the American Academy of Neurology Annual Meeting 2021 finance.yahoo.com - April 8 at 12:59 PM
	Could The Avadel Pharmaceuticals plc (NASDAQ:AVDL) Ownership Structure Tell Us Something Useful? finance.yahoo.com - March 29 at 8:17 AM
	Avadel Pharmaceuticals to Participate in a Fireside Chat at Stifel’s Third Annual CNS Day on ... apnews.com - March 19 at 4:45 AM
	Avadel Pharmaceuticals to Participate in a Fireside Chat at Stifel’s Third Annual CNS Day on March 31st finance.yahoo.com - March 18 at 8:18 AM
	Revenue Downgrade: Here's What Analysts Forecast For Avadel Pharmaceuticals plc (NASDAQ:AVDL) nasdaq.com - March 11 at 9:34 AM
	Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 ... apnews.com - March 10 at 1:13 AM
	Avadel Pharmaceuticals plc (AVDL) Q4 2020 Earnings Call Transcript fool.com - March 9 at 3:32 PM
	Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results Nasdaq:AVDL compsmag.com - March 9 at 2:58 PM
	Avadel: Q4 Earnings Snapshot finance.yahoo.com - March 9 at 9:54 AM
	Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results finance.yahoo.com - March 9 at 9:54 AM
	Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an ... apnews.com - March 5 at 12:52 AM
	Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2021 Young Investigators Research Forum finance.yahoo.com - March 4 at 9:51 AM
	Argobio announces its launch with 50 M€ to create… pharmiweb.com - March 3 at 7:43 AM
	Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults ... apnews.com - March 2 at 10:07 AM

Date	Company	Brokerage	Action
4/27/2021	Molecular Templates	Bank of America	Initiated Coverage
4/15/2021	Molecular Templates	Oppenheimer	Lower Price Target
4/6/2021	Molecular Templates	Jefferies Financial Group	Boost Price Target
2/1/2021	Molecular Templates	UBS Group	Initiated Coverage
3/25/2020	Molecular Templates	Stifel Nicolaus	Initiated Coverage
2/27/2020	Molecular Templates	Barclays	Initiated Coverage
11/13/2019	Molecular Templates	Cowen	Reiterated Rating
12/11/2018	Molecular Templates	CIBC	Initiated Coverage
12/10/2018	Molecular Templates	LADENBURG THALM/SH SH	Reiterated Rating
11/15/2018	Molecular Templates	Evercore ISI	Initiated Coverage
10/8/2018	Molecular Templates	Laidlaw	Initiated Coverage
3/30/2021	AC Immune	HC Wainwright	Boost Price Target
11/12/2018	AC Immune	SVB Leerink	Initiated Coverage
4/8/2021	Verastem	Cantor Fitzgerald	Reiterated Rating
8/2/2019	Verastem	B. Riley	Set Price Target
6/20/2019	Verastem	BTIG Research	Downgrade
5/14/2019	Verastem	Roth Capital	Lower Price Target
5/10/2019	Verastem	Raymond James	Downgrade
7/27/2018	Verastem	Seaport Global Securities	Set Price Target
4/7/2020	XBiotech	Piper Sandler	Lower Price Target
12/11/2019	XBiotech	Piper Jaffray Companies	Boost Price Target
11/9/2020	Avadel Pharmaceuticals	Lifesci Capital	Reiterated Rating
8/11/2020	Avadel Pharmaceuticals	Ci Capital	Reiterated Rating
4/3/2020	Avadel Pharmaceuticals	Craig Hallum	Boost Price Target
8/7/2018	Avadel Pharmaceuticals	JMP Securities	Downgrade
8/7/2018	Avadel Pharmaceuticals	SunTrust Banks	Downgrade

(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources